HONG KONG, Dec. 19, 2024 /PRNewswire/ -- The "You've Got a Friend" charity concert, organized by the Hong Kong Mental Wellness Association, will take place from April 9 to 11, 2025, at the Rita Tong Liu Drama Theatre of the Hong Kong Academy for Performing Arts. The concert aims to raise public awareness about mental wellness. Veteran media personality Brian Chow will serve as the director and talk show host. At the same time, renowned singer and HiFi diva Susan Wong will perform to convey positive messages and an optimistic attitude towards emotional well-being.
To further promote awareness of emotional health, the Hong Kong Mental Wellness Association held a press conference for the charity concert in mid-December 2024. During the event, Brian Chow and Susan Wong discussed the concert's objectives and preparation process. Former Miss Hong Kong winner Virginia Yung shared her experiences with emotional struggles.
Brian Chow, a beacon of hope in the fight against emotional disorders, reflected on the past two decades. He stated, "I often ask myself if I have emotional problems without realizing it. Fortunately, I have not magnified this worry and frequently remind my friends that if they suspect they have emotional issues, they should share their feelings with others and seek professional help if necessary." He emphasized that emotional disorders are pervasive, and people sometimes choose to avoid confronting their problems. This is one of the reasons he is participating in the charity concert, hoping to encourage those around him to understand that "there's always a friend by your side; You've Got a Friend!"
Susan Wong, who balances her roles as a practicing accountant, wife, and mother, spoke about the pressures and challenges of her multiple identities. She shared, "I listen to music when I'm happy, and when I'm not, singing helps relieve my mood. Through this concert, I hope to use my music to heal everyone's emotional health and help those struggling with emotional issues release their stress and find a brighter future. It's okay not to be okay!"
Your support is crucial in our mission to promote mental wellness. Tickets for the 'You've Got a Friend' charity concert, priced at $980, $680, $480, and $280, are now available online at www.cityline.com or by calling the ticket hotline at (852) 2111 5333. We look forward to your participation in this meaningful event.
YouTube link:
https://www.youtube.com/watch?v=lDv3lb4j0FY
Download link for pictures:
https://www.dropbox.com/scl/fo/24tbpdtyeff8wgqrc0gz2/AHVx38q82O2VnK0rjwKOfEk?rlkey=ua618pi6ljvix8hikwqxuj2tb&st=b8x1ppc5&dl=0
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
"You've Got a Friend" Charity Concert Aims to Promote Mental Wellness
BEIJING, March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together the strengths of both companies to drive innovation, streamline product development, and expand market reach.
Harnessing Expertise to Transform the Industry
Synthetic biology is rapidly emerging as a transformative field with wide-reaching applications, including precision medicine, bio-breeding, and gene editing. At the core of these advancements are high-throughput and column-based synthesis, which Tsingke Biotech and iGeneTech aim to further develop.
Tsingke Biotech, a leader in gene synthesis, has developed a fully integrated industrial chain that spans raw materials, equipment, process design, AI, and digital technologies. Known for its scalability, standardization, and stability, the company's cutting-edge technology includes column synthesis and an intelligent factory-driven production system that supports from small-scale laboratory production (2nmol) to large-scale industrial synthesis (12mmol). Their gene synthesis services include:
- Primer Synthesis (<300nt)
- Gene Synthesis (300bp–5kb)
- Long Gene Synthesis (>5kb)
On the other hand, iGeneTech contributes its proprietary Ignite 3.0 high-throughput synthesis platform. With its ability to process oligo pools ranging from 4k to 650k in size and achieve synthesis lengths up to 200nt with error rates as low as 0.2%, this platform addresses key challenges around throughput, speed, and cost.
A Shared Vision for Growth
"We are excited to partner with iGeneTech, whose expertise in gene capture and next-generation sequencing (NGS) technology enhances our strengths in gene synthesis," said Mr. Shijin Ma, CEO of Tsingke Biotech. "This partnership will speed up the translation of technological innovations into real-world applications, helping drive the industry forward."
Mr. Wanshi Cai, CEO of iGeneTech, added, "Tsingke Biotech's integrated industrial chain and leadership in gene synthesis will be crucial in supporting our continued growth. Together, we will push the boundaries of synthetic biology and its potential across various industries."
Both companies are committed to developing an integrated system that spans the entire spectrum from "synthesis" to "application," focusing on innovation, sustainability, and precision to meet the needs of a rapidly evolving market.
About Tsingke Biotech
Tsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven molecular manufacturing technologies, Tsingke Biotech provides efficient and high-quality gene synthesis services. Its work supports industries ranging from biopharma to agriculture, food, and environmental sciences.
About iGeneTech
iGeneTech specializes in gene capture technologies and holds intellectual property in NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis. The company's high-quality oligo pool synthesis capabilities enable the creation of precise and uniform sgRNA libraries for gene-editing applications, including genome-wide and target-gene sgRNA libraries, and off-target detection.
Contact: market@tsingke.com.cn
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
